Tag: Health Care

Displaying 641 - 660 of 1054 results.

Pages

Commission issuance of information requests: The Commission has issued information requests to generic and authorized generic drug manufacturers and marketers as part of its ongoing study of the short- and long-term effects of authorized generics on pharmaceutical drug competition. The current set...
Two marketers of non-corrective, cosmetic contact lenses have agreed to settle Federal Trade Commission charges that they violated federal law by selling lenses without prescriptions.
The Federal Trade Commission today announced a complaint challenging Schering-Plough Corporation’s proposed $14.4 billion acquisition of Organon BioSciences N.V. from Akzo-Nobel N.V., alleging that the deal would harm competition in the U.S. markets for the manufacture and development of three...
Commission approval of amended complaint filing: The Commission has approved the filing of an amended complaint in the matter currently pending against Direct Marketing Concepts, Inc., et al. The original complaint in this case, announced earlier this month, charged the marketers of Kevin Trudeau’s...
Providing Federal Trade Commission testimony today before the Antitrust Task Force of the U.S. House of Representatives’ Committee on the Judiciary, Deputy Bureau of Competition Director David P. Wales, Jr., presented the Commission’s views on H.R. 971, the Community Pharmacy Fairness Act of 2007,...
On October 12, Federal Trade Commission staff sent warning letters to 15 sellers of non-corrective, cosmetic contact lenses who appeared to be providing contact lenses to consumers without valid prescriptions. Under the FTC’s Contact Lens Rule, sellers of both corrective and non-corrective cosmetic...
The Federal Trade Commission today announced a complaint challenging Kyphon, Inc.’s (Kyphon) proposed acquisition of the spinal assets of Disc-O-Tech Medical Technologies, Ltd. and Discotech Orthopedic Technologies, Inc. (collectively Disc-O-Tech) as anticompetitive in the U.S. market for minimally...
The Commission challenged Kyphon Inc.’s $220 million proposed acquisition of the spinal assets of Disc-O-Tech Medical Technologies, Ltd. and Discotech Orthopedic Technologies (collectively Disc-O-Tech) as anticompetitive in the market for minimally invasive vertebral compression...
Commission approval of filing of staff comments: The Commission has approved the filing of comments by the staff of the Office of Policy Planning and the Bureaus of Economics, Competition, and Consumer Protection with the Massachusetts Department of Public Health (DPH) regarding proposed limited...
The Commission ordered divestitures to resolve competitive concerns in the U.S. market for five generic drugs stemming from Mylan Laboratories’ proposed acquisition of the generic arm of Merck Pharmaceuticals, a transaction valued at approximately $6.6 billion. Under a September 2007...
The Federal Trade Commission today announced its challenge of Mylan Laboratories’ (Mylan) proposed $6.6 billion acquisition of Germany’s E. Merck oHG (Merck), alleging that the transaction would result in significantly reduced competition for the sale and manufacture of five generic drugs in the U....
Staff of the Federal Trade Commission have advised the Greater Rochester Independent Practice Association, Inc. (GRIPA), a multi-specialty physician practice association that includes competing primary care and specialist physicians that practice in the three-county greater Rochester, New York,...
Commission approval of final consent orders: The Commission has approved a final consent order in the matter concerning the South Carolina State Board of Dentistry and approved letters to the commenters of record. The FTC vote approving the final consent order was 5-0. (FTC Docket No. D-9311; the...
The Commission settled charges stemming from American Renal Associates’ (ARA) proposed acquisition of assets from Fresenius AG, which would have made ARA the only operator of dialysis clinics in the Warwick/Cranston area of Rhode Island. The purchase agreement called for the sale of...
The Federal Trade Commission today announced a consent order settling charges that two dialysis clinic operators – American Renal Associates, Inc. and Fresenius Medical Care Holdings, Inc. – unlawfully restrained competition in violation of Section 5 of the FTC Act when ARA paid Fresenius to close...
In an administrative opinion and order made public today, the Federal Trade Commission ruled that Evanston Northwestern Healthcare Corp.’s (ENH) acquisition of Highland Park Hospital (Highland Park) in 2000 was anticompetitive and violated Section 7 of the Clayton Act. The Commission opinion,...
A group representing all optometrists in Puerto Rico, along with two of its leaders, has agreed to settle Federal Trade Commission charges that they violated the FTC Act by orchestrating and carrying out agreements among the group’s members to refuse, and threaten to refuse, to deal with payors,...
The Commission charged a group of optometrists in Puerto Rico with violating the FTC Act by orchestrating agreements among members of the Colegio de Optometras to refuse, or threaten to refuse, to accept vision and health care contracts except on collectively agreed-upon terms. Two...
The Federal Trade Commission today announced a consent order settling charges brought in September 2003 that the South Carolina State Board of Dentistry unlawfully restrained competition in violation of Section 5 of the FTC Act by adopting a rule that required a dentist to examine every child...
Protecting competition and consumers, the Federal Trade Commission today announced it is challenging Rite Aid Corporation’s proposed $3.5 billion acquisition of the Brooks and Eckerd pharmacies from Canada’s Jean Coutu Group (PJC), Inc. To remedy the alleged anticompetitive impact of the proposed...

Pages